Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case...

Area of Science:

• Cardiology
• Clinical Trials
• Ischemic Heart Disease Management

Background:

• Guideline-directed medical therapy (GDMT) is recommended for stable ischemic heart disease (SIHD) to manage atherosclerosis and prevent thrombosis.
• Revascularization is considered for SIHD patients with persistent symptoms despite medical management.

Purpose of the Study:

• To determine if routine revascularization plus GDMT reduces death or myocardial infarction rates compared to GDMT alone in patients with substantial ischemia.
• To evaluate the impact of revascularization strategies on quality of life in SIHD patients with moderate-to-severe ischemia.

Main Methods:

• The ISCHEMIA trial is an ongoing international study comparing medical therapy with an invasive approach (revascularization) in SIHD patients.
• Participants have moderate-to-severe ischemia and medically controlled symptoms.
• Outcomes include death, myocardial infarction, and quality of life.

Main Results:

• Current evidence is insufficient to definitively favor routine revascularization over GDMT alone for SIHD patients with substantial ischemia.
• There is community equipoise regarding the optimal management strategy.
• The ISCHEMIA trial aims to resolve this uncertainty.

Conclusions:

• The optimal management strategy for stable ischemic heart disease with moderate-to-severe ischemia remains uncertain.
• The ISCHEMIA trial is crucial for establishing evidence-based recommendations for invasive versus conservative treatment approaches.
• Further data are needed to guide clinical decision-making in this patient population.